
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.
Research published in the April print edition of the journal Life Science Alliance, shows that antidepressant drugs called FIASMAs, including desipramine, amitriptyline, and nortriptyline, halt the growth or kill four different intracellular bacterial pathogens in tissue cell culture and animal models.
“Antibiotic options for diseases caused by intracellular bacteria are limited because many of these drugs cannot penetrate our cell membranes. In essence, the bacteria are protected,” said Jason Carlyon, Ph.D., leader of the study and professor in the VCU Department of Microbiology and Immunology.
Tetracycline antibiotics are most commonly prescribed to treat intracellular bacterial infections because they can cross cell membranes to reach the microbes. However, tetracyclines can cause allergic reactions in some patients and physicians advise against their use by pregnant women and children due to undesirable side effects. Additionally, antibiotic resistance in some intracellular bacteria has been reported.
“It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated,” Carlyon said. “These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetti.”
The team of researchers from VCU, Indiana University Medical Center, University of Nebraska Medical Center, University of Arkansas for Medical Sciences, and the University of South Florida, including Carlyon and lead author Chelsea Cockburn, an M.D.-Ph.D. candidate, are the first to investigate the mechanisms by which FIASMAs target multiple intracellular bacteria in detail.
The scientists tested FIASMA susceptibility for four bacterial species that cause human granulocytic anaplasmosis, a tick-borne disease that attacks white blood cells called neutrophils and can be fatal to immune compromised individuals; Q fever, a debilitating pneumonic disease; and two chlamydia infections.
FIASMAs ultimately disrupt how cholesterol, a key nutrient utilized by many intracellular pathogens, traffics inside cells to alter bacterial access to the lipid. The researchers first proved FIASMA treatment efficacy by halting anaplasmosis in both tissue culture and mice. Next, they extended their observations to demonstrate that FIASMA treatment killed the Q fever agent,Coxiella burnetii, and partially inhibited chlamydial infections in cell culture.
“Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases,” Carlyon said.
He added that the effect of FIASMAs on intracellular cholesterol ultimately bypasses the need to directly target the bacteria.
“What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria,” Carlyon said. “I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body.”
Learn more: Certain antidepressants could provide a frontline treatment for multiple infectious diseases, testing shows
The Latest on: Alternative to antibiotics
[google_news title=”” keyword=”alternative to antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alternative to antibiotics
- How To Get Antibiotics For UTI Without Seeing A Doctoron July 26, 2024 at 12:13 pm
Antibiotics are drugs that are used specifically to treat bacterial infections, that is, infections caused by microorganisms.
- Stewardship intervention linked to reduced antibiotic use in pediatric long-term careon July 25, 2024 at 12:03 pm
The intervention at a pediatric long-term care facility was associated with sustained reductions in ciprofloxacin and other antibiotic use without increasing negative outcomes.
- UIC scientists develop combo antibiotic that can prevent superbugson July 24, 2024 at 3:16 am
A series of discoveries about the chemistry of antibiotics and the ribosomes they target may have found a way around bacteria's pesky ability to evolve resistances.
- The development of a better antibiotic – and moreon July 23, 2024 at 2:40 pm
For Tuesday, July 23, WGN’s Dina Bair has the latest on new medical information, including: More Coverage: WGN’s Medical Watch At the University of Illinois Chicago, scientists developed an antibiotic ...
- Dual action antibiotic could make bacterial resistance nearly impossibleon July 22, 2024 at 5:00 pm
A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research from the University ...
- Peptide cocktails show promise in combating antibiotic resistanceon July 22, 2024 at 12:25 pm
Antibiotics are essential tools in modern medicine, regularly used to treat bacterial infections and prevent infections during surgery. However, the widespread use of antibiotics has led to many ...
- Fighting Antibiotic Resistance with Peptide Cocktailson July 21, 2024 at 5:00 pm
Antibiotics are crucial in modern medicine, but their widespread use has led to antibiotic-resistant bacteria, posing a serious public health threat. A new study highlights the potential of random ...
- Meitheal buys rights to drug that can fight antibiotic-resistant strainson July 19, 2024 at 3:15 am
Meitheal Pharmaceuticals has acquired the North American rights to a novel antibiotic for treating complicated urinary tract infections.
- Antibiotic Resistance: How It Happens and How You Can Prevent Iton July 17, 2024 at 9:06 am
Antibiotic resistance develops when antibiotics are misused. Read on to learn more about what antibiotic resistance is, how it develops, and the role you can play in preventing it from continuing.
- New Approach to Finding Antibiotic Alternatives Using Bacterial Dataon July 17, 2024 at 8:12 am
Researchers have devised an approach for identifying novel antimicrobial drugs with clinical potential using bacterial databases, offering insights into finding alternatives to existing antibiotics.
via Bing News